WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
HK Stock Market Move | LAEKNA-B(02105) rose more than 5% at the close, Qilu Pharmaceutical will advance the domestic listing application of LAE002.
Shell (SHEL.US) exceeded expectations in the first quarter profit: surge in oil and gas prices boosted trading business, but buyback activities shrank.
A-share market closing review | Partial profit-making effect explodes A-share market "continues to play music and dance"! ChiNext rose by 1.45%, hitting a new high in ten years.
HK Stock Market Move | LAEKNA-B(02105) rose more than 5% at the close, Qilu Pharmaceutical will advance the domestic listing application of LAE002.
Shell (SHEL.US) exceeded expectations in the first quarter profit: surge in oil and gas prices boosted trading business, but buyback activities shrank.
A-share market closing review | Partial profit-making effect explodes A-share market "continues to play music and dance"! ChiNext rose by 1.45%, hitting a new high in ten years.
